Finucane, Francis

3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial

le Roux, C. W., Astrup, A., Fujioka, K., Greenway, F., Lau, D. C. W., Van Gaal, L., Ortiz, R. V., Wilding, J. P. H., Skjøth, T. V., Manning, L. S., et al. (2017) · The Lancet

Diabetes Treatment and ManagementPharmacology and Obesity Treatment

Cited by 850

Behaviour change techniques targeting both diet and physical activity in type 2 diabetes: a systematic review and meta-analysis

Cradock, K. A., ÓLaighin, G., Finucane, F. M., Gainforth, H. L., Quinlan, L. R., & Ginis, K. A. M. (2017) · International Journal of Behavioral Nutrition and Physical Activity

Behavioral Health and InterventionsDiabetes Management and Education

Cited by 343

Genetic variation near IRS1 associates with reduced adiposity and an impaired metabolic profile

Kilpeläinen, T. O., Zillikens, M. C., Stančákova, A., Finucane, F. M., Ried, J. S., Langenberg, C., Zhang, W., Beckmann, J. S., Luan, J., Vandenput, L., et al. (2011) · Nature Genetics

Genetic Associations and EpidemiologyAdipokines, Inflammation, and Metabolic Diseases

Cited by 335

Subjects With Early-Onset Type 2 Diabetes Show Defective Activation of the Skeletal Muscle PGC-1α/Mitofusin-2 Regulatory Pathway in Response to Physical Activity

Hernández-Alvarez, M. I., Thabit, H., Burns, N., Shah, S., Brema, I., Hatunic, M., Finucane, F., Liesa, M., Chiellini, C., Naon, D., et al. (2010) · Diabetes Care

Adipose Tissue and MetabolismMetabolism, Diabetes, and Cancer

Cited by 189

Conventional glucocorticoid replacement overtreats adult hypopituitary patients with partial ACTH deficiency

Agha, A., Liew, A., Finucane, F., Baker, L., O'Kelly, P., Tormey, W., & Thompson, C. J. (2004) · Clinical Endocrinology

Adrenal Hormones and DisordersPituitary Gland Disorders and Treatments

Cited by 45

Identifying Barriers and Facilitators to Diet and Physical Activity Behaviour Change in Type 2 Diabetes Using a Design Probe Methodology

Cradock, K. A., Quinlan, L. R., Finucane, F. M., Gainforth, H. L., Martin Ginis, K. A., Barros, A. C. D., Sanders, E. B. N., & ÓLaighin, G. (2021) · Journal of Personalized Medicine

Diabetes Management and EducationBehavioral Health and Interventions

Cited by 32

Prolonged acidosis is a feature of SGLT2i-induced euglycaemic diabetic ketoacidosis

Rafey, M. F., Butt, A., Coffey, B., Reddington, L., Devitt, A., Lappin, D., & Finucane, F. M. (2019) · Endocrinology, Diabetes & Metabolism Case Reports

Diabetes Treatment and ManagementDiabetes Management and Research

Cited by 29

Obesity drug shortages are symptomatic of wider malaise

Sumithran, P., Finucane, F. M., & Cohen, R. V. (2024) · The Lancet

Pharmacology and Obesity TreatmentPharmaceutical Economics and Policy

Cited by 16

Changes in alanine aminotransferase in adults with severe and complicated obesity during a milk-based meal replacement programme

Abdalgwad, R., Rafey, M. F., Murphy, C., Ioana, I., O’Shea, P. M., Slattery, E., Davenport, C., O’Keeffe, D. T., & Finucane, F. M. (2020) · Nutrition & Metabolism

Liver Disease Diagnosis and TreatmentBariatric Surgery and Outcomes

Cited by 6